Apollo Hospitals Enterprise Ltd vs Avience Biomedicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Apollo Hospitals Enterprise Ltd is ₹ 7731 as of 23 Oct 15:30 . The P/E Ratio of Apollo Hospitals Enterprise Ltd changed from 277.5 on March 2021 to 55 on March 2026 . This represents a CAGR of -23.64% over 6 yearsThe P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Apollo Hospitals Enterprise Ltd changed from ₹ 41739 crore on March 2021 to ₹ 106808 crore on March 2026 . This represents a CAGR of 16.95% over 6 yearsThe Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Apollo Hospitals Enterprise Ltd for the Jun '26 is ₹ 7105 crore as compare to the Mar '26 revenue of ₹ 6659 crore. This represent the growth of 6.7% The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Apollo Hospitals Enterprise Ltd for the Jun '26 is ₹ 1154 crore as compare to the Mar '26 ebitda of ₹ 1065 crore. This represent the growth of 8.38% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Apollo Hospitals Enterprise Ltd changed from ₹ 315.5 crore to ₹ 610.4 crore over 9 quarters. This represents a CAGR of 34.09% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Apollo Hospitals Enterprise Ltd changed from 41.09 % on March 2021 to 19.27 % on March 2026 . This represents a CAGR of -11.86% over 6 yearsThe Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Limited (AHEL) is a leading private sector healthcare provider in Asia.
It has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics.
AHEL's Hospitals are situated in Chennai, Hyderabad, Delhi, Ahmedabad, Pune, Chenganur, Coimbatore, Jaipur, Madurai, Anantpur, Nellore, Kurnool, Bhopal, Ranchi, Bilaspur and Bacheli.
The principal activities of the Company include operation of multidisciplinary private hospitals, clinics and pharmacies. Apollo Hospitals Enterprise Limited was incorporated as a Public Limited Company on December 5, 1979, a comprehensive 250-bed hospital with an emphasis on speciality and super specialties in over fifty departments at Chennai.
Dr. Prathap C. Reddy promoted it. 46 beds were added in the year 1985.

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

FAQs for the comparison of Apollo Hospitals Enterprise Ltd and Avience Biomedicals Ltd

Which company has a larger market capitalization, Apollo Hospitals Enterprise Ltd or Avience Biomedicals Ltd?

Market cap of Apollo Hospitals Enterprise Ltd is 111,173 Cr while Market cap of Avience Biomedicals Ltd is 131 Cr

What are the key factors driving the stock performance of Apollo Hospitals Enterprise Ltd and Avience Biomedicals Ltd?

The stock performance of Apollo Hospitals Enterprise Ltd and Avience Biomedicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Apollo Hospitals Enterprise Ltd and Avience Biomedicals Ltd?

As of October 25, 2026, the Apollo Hospitals Enterprise Ltd stock price is INR ₹7731.95. On the other hand, Avience Biomedicals Ltd stock price is INR ₹240.0.

How do dividend payouts of Apollo Hospitals Enterprise Ltd and Avience Biomedicals Ltd compare?

To compare the dividend payouts of Apollo Hospitals Enterprise Ltd and Avience Biomedicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.